Sarepta Therapeutics Stock Forecast

Stock Price Forecast

The 26 analysts that cover Sarepta Therapeutics stock have a consensus rating of "Hold" and an average price target of $25.85, which forecasts a 22.11% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $81.

Price Target: $25.85 (+22.11%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$5.00	$25.85	$20	$81
Change	-76.38%	+22.11%	-5.53%	+282.62%

Analyst Ratings

The average analyst rating for Sarepta Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	4	3	3	3	3	3
Buy	7	7	7	7	7	7
Hold	13	13	13	13	13	13
Sell	2	2	2	2	2	2
Strong Sell	4	4	4	4	4	4
Total	30	29	29	29	29	29

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell S. Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Sell Reiterates $5	Strong Sell	Reiterates	$5	-76.38%	Apr 16, 2026
Yigal Nochomovitz Citigroup	Citigroup	Strong Sell Maintains $9 → $13	Strong Sell	Maintains	$9 → $13	-38.59%	Mar 26, 2026
Gil Blum Needham	Needham	Sell Reiterates n/a	Sell	Reiterates	n/a	n/a	Mar 26, 2026
Kostas Biliouris Oppenheimer	Oppenheimer	Buy Reiterates $37	Buy	Reiterates	$37	+74.78%	Mar 19, 2026
Uy Ear Mizuho	Mizuho	Buy Maintains $26 → $31	Buy	Maintains	$26 → $31	+46.43%	Mar 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.77B

from 2.20B

-19.48%

from 2.20B

Revenue Next Year

1.47B

from 1.77B

-17.01%

from 1.77B

EPS This Year

3.13

from -7.13

EPS Next Year

1.68

from 3.13

-46.17%

from 3.13

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	701.89M	933.01M	1.24B	1.90B	2.20B	1.77B	1.47B
Revenue Growth	29.96%	32.93%	33.26%	52.97%	15.58%	-19.48%	-17.01%
EPS	-5.15	-8.03	-5.80	2.34	-7.13	3.13	1.68
EPS Growth	-	-	-	-	-	-	-46.17%
Forward PE	-	-	-	-	-	6.77	12.58
No. Analysts	-	-	-	-	-	28	25

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	2.0B	2.0B
Avg	1.8B	1.5B
Low	1.4B	865.7M

Revenue Growth

Revenue Growth	2026	2027
High	-9.7%	11.9%
Avg	-19.5%	-17.0%
Low	-36.9%	-51.1%

EPS Forecast

EPS	2026	2027
High	5.86	5.18
Avg	3.13	1.68
Low	0.80	-0.21

EPS Growth

EPS Growth	2026	2027
High	-	65.5%
Avg	-	-46.2%
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.